These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1231877)

  • 21. [Use of potassium canrenoate in cardiosurgery].
    Tufano R; Scopa M; Brando G; Leone D
    Minerva Anestesiol; 1981 Apr; 47(4):149-54. PubMed ID: 7242963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)].
    Capuani A; Bernabei M; Pasque A; Eufrate S
    G Ital Cardiol; 1980; 10(9):1148-55. PubMed ID: 7461364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Brain edema in neurosurgery. Trial with an aldosterone-antagonist (soldactone) (author's transl)].
    Anderes JP; de Tribolet N; Zander E
    Schweiz Rundsch Med Prax; 1977 Aug; 66(32):1020-6. PubMed ID: 556440
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
    Matsuda K; Tatsuta N; Konishi Y; Minami K; Nishiwaki N; Yamasato A; Chiba Y; Ishihara H; Murata S; Shiraishi Y; Muraguchi T; Hikasa Y
    Nihon Geka Hokan; 1982 May; 51(3):519-27. PubMed ID: 7138201
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F; Remonda G; Morachioli N; Pugnani M
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M; Vizzini GB
    Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.
    Cristodorescu R; Puschita M; Deutsch G; Berger E; Luca C
    Med Interne; 1977; 15(1):27-34. PubMed ID: 841250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of advanced respiratory insufficiency using potassium canreonate (Aldactone). Preliminary report].
    Kerjaschki A
    Wien Med Wochenschr; 1976 Dec; 126(49-50):705-7. PubMed ID: 795170
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis].
    Ikebe H; Hoashi S; Irie F; Taniguchi K; Honda N; Mitarai Y; Kobayashi N
    Masui; 1988 May; 37(5):546-51. PubMed ID: 3045361
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aldosterone antagonists in coronary insufficiency].
    Osswald H
    Med Klin; 1978 Jan; 73(3):84-8. PubMed ID: 622061
    [No Abstract]   [Full Text] [Related]  

  • 32. [False values of blood digoxin in patients with acute and chronic liver disease. Role of canrenoate potassium and comparison of radioimmunologic and immunoenzymatic methods].
    Nardoni A; di Piazza V; Moretti V; Copetti R; Trinco G; Geatti O
    Clin Ter; 1988 May; 125(4):287-90. PubMed ID: 2974364
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M; Cuppone R; Ricci GL
    Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of Soludactone in cardiac surgery in adults].
    Fogliani J; Capuccio P; Goudard A; Guillen JC; Monties JR
    Ann Anesthesiol Fr; 1975; 16(3):189-96. PubMed ID: 241276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
    Tartagni F; Ambrosioni E
    Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037
    [No Abstract]   [Full Text] [Related]  

  • 36. [Double-blind study on the effects of potassium canrenoate on perifocal edema in acute cerebral ischemia].
    Bidabé AM; Floras P; Orgogozo JM; Péré JM; Dartigues JF; Caillé JM
    Agressologie; 1982; 23(C):35-41. PubMed ID: 7125090
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of furosemide, potassium canrenoate and D-L-propranolol on blood pressure in spontaneously hypertensive rat].
    Altman J; Gordan P; Grünfeld JP
    Pathol Biol (Paris); 1976 May; 24(5):337-41. PubMed ID: 781602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Potassium canrenoate and the combination of potassium canrenoate-butizide in the therapy of light to moderate arterial hypertension].
    Morabito S; Fabiano M; Puliti M; Palumbo R; Marinelli R; Simonetti BM; Pierucci A
    Clin Ter; 1992 Jul; 141(7):23-8. PubMed ID: 1505173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of plasma renin activity and urinary excretion of aldosterone in patients with essential hypertension treated with D-L propranolol].
    Bompiani GD; Scaduto P; Galluzzo A; Morici ML; Mangano MT; Donatelli M
    Minerva Cardioangiol; 1976; 24(7-8):498-505. PubMed ID: 1018743
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma digoxin radioimmunoassay in patients treated with potassium canrenoate and spironolactone. A comparison of two commerical kits.
    Cristodorescu R; Gavrilescu S; Deutsch G; Berger E
    Agressologie; 1978; 19(6):409-14. PubMed ID: 751526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.